1. Home
  2. LSEA vs ALDX Comparison

LSEA vs ALDX Comparison

Compare LSEA & ALDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LSEA
  • ALDX
  • Stock Information
  • Founded
  • LSEA 2013
  • ALDX 2004
  • Country
  • LSEA United States
  • ALDX United States
  • Employees
  • LSEA N/A
  • ALDX N/A
  • Industry
  • LSEA Homebuilding
  • ALDX Biotechnology: Pharmaceutical Preparations
  • Sector
  • LSEA Consumer Discretionary
  • ALDX Health Care
  • Exchange
  • LSEA Nasdaq
  • ALDX Nasdaq
  • Market Cap
  • LSEA 222.1M
  • ALDX 133.7M
  • IPO Year
  • LSEA N/A
  • ALDX 2014
  • Fundamental
  • Price
  • LSEA $6.10
  • ALDX $2.16
  • Analyst Decision
  • LSEA Buy
  • ALDX Strong Buy
  • Analyst Count
  • LSEA 4
  • ALDX 2
  • Target Price
  • LSEA $13.50
  • ALDX $9.50
  • AVG Volume (30 Days)
  • LSEA 200.4K
  • ALDX 1.5M
  • Earning Date
  • LSEA 05-12-2025
  • ALDX 05-20-2025
  • Dividend Yield
  • LSEA N/A
  • ALDX N/A
  • EPS Growth
  • LSEA N/A
  • ALDX N/A
  • EPS
  • LSEA 0.47
  • ALDX N/A
  • Revenue
  • LSEA $1,550,337,000.00
  • ALDX N/A
  • Revenue This Year
  • LSEA N/A
  • ALDX N/A
  • Revenue Next Year
  • LSEA $3.52
  • ALDX N/A
  • P/E Ratio
  • LSEA $12.98
  • ALDX N/A
  • Revenue Growth
  • LSEA 28.13
  • ALDX N/A
  • 52 Week Low
  • LSEA $5.41
  • ALDX $1.14
  • 52 Week High
  • LSEA $14.04
  • ALDX $7.20
  • Technical
  • Relative Strength Index (RSI)
  • LSEA 48.21
  • ALDX 34.82
  • Support Level
  • LSEA $5.79
  • ALDX $1.90
  • Resistance Level
  • LSEA $6.25
  • ALDX $2.89
  • Average True Range (ATR)
  • LSEA 0.31
  • ALDX 0.23
  • MACD
  • LSEA 0.04
  • ALDX 0.10
  • Stochastic Oscillator
  • LSEA 43.02
  • ALDX 26.26

About LSEA Landsea Homes Corporation

Landsea Homes Corp is a growth-oriented homebuilder focused on providing High-Performance Homes that deliver energy-efficient living in attractive geographies. It is engaged in the design, construction, marketing and sale of suburban and urban single-family detached and attached homes in Arizona, California, Colorado, Florida, Texas, and Metro New York. While It offers a wide range of housing options, it focuses on entry-level and first-time move-up homes and believes its markets are characterized by attractive long-term housing fundamentals. The company's segments include Arizona, California, Colorado, Florida, Metro New York, and Texas. It derives a majority of its revenue from home sales in Florida.

About ALDX Aldeyra Therapeutics Inc.

Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.

Share on Social Networks: